Use of botulinum toxin in stroke patients with severe upper limb spasticity

Journal of Neurology Neurosurgery and Psychiatry

Volumn 61, Issue 1, 1996, Pages 30-35

  Bhakta, B B ^a   Cozens, J A ^a   Bamford, J M ^b   Chamberlain, M A ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Botulinum toxin; Spasticity; Stroke

Indexed keywords

BOTULINUM TOXIN; BOTULINUM TOXIN A;

ADOLESCENT; ADULT; AGED; ARM; ARM MOVEMENT; ARTICLE; BICEPS BRACHII MUSCLE; CLINICAL ARTICLE; CLINICAL TRIAL; DAILY LIFE ACTIVITY; DRUG EFFICACY; ELBOW; FEMALE; FINGER; FOREARM; HUMAN; HYGIENE; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; SHOULDER; SPASTICITY; STANDING; STROKE; WALKING; WRIST;

EID: 0030016259     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.61.1.30     Document Type: Article

References (18)

1. Gowland C. Management of hemiplegic upper limb. In: Brandstater ME, Basmajian JV, eds. Stroke rehabilitation. Baltimore: Williams and Wilkins, 1987:217-45.
2. Skeil DA, Barnes MP. The local treatment of spasticity. Clin Rehabil 1994;8:240-6.
3. Scott AB. Botulinum toxin injection of eye muscles to correct strabismus. Trana Am Ophthalmol Soc 1981;79: 734-70.
4. Scott AB, Kennedy RA, Stubbs HA. Botulinum toxin injection as a treatment for blepharospasm. Arch Ophthalmol 1985;103:347-50.
5. Flanders M, Chin D, Boghen D. Botulinum toxin: preferred treatment for hemifacial spasm. Eur Neurol 1993; 33;316-9.
6. Andersen TJ, Rivest J, Stell R, et al. Botulinum toxin treatment of spasmodic torticollis. J R Soc Med 1992;85: 524-9.
7. Jankovics J. Botulinum toxin in movement disorders. Current Opinions in Neurology 1994;7:358-66.
8. Das TK, Park DM. Effect of treatment with botulinum toxin on spasticity. Postgrad Med J 1989;65:208-10.
9. Snow BJ, Tsui JK, Bhatt MH, Varelas M, Hashimoto SA, Calne DB. Treatment of spasticity with botulinum toxin: a double blind study. Ann Neurol 1990;28:512-5.
10. Borodic GE. Botulinum toxin potency: a mystery resolved by the median paralysis unit. J R Coll Phys 1994;87: 571-2.
11. Bohannon RW, Smith MB: Interrater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther 1987; 67:206-7.
12. Mahoney FI, Barthel DW. Functional evaluation: the Barthel index. MD Med J 1965;14:61-5.
13. Hesse S, Friedrich H, Domasch C, Mauritz K. Botulinum toxin therapy for upper limb flexor spasticity: preliminary results. J Rehabil Sci 1992;5:98-101.
14. Lincoln N, Leadbitter D. Assessment of motor function in stroke patients. Physiotherapy 1979;65:48-51.
15. Tugwell P, Bombardier C, Buchanan WW, Goldsmith CH, Grace E, Hanna B. The MACTAR patient preference disability questionnaire - an individualised functional priority approach for assessing improvement in physical disability in clinical trials in rheumatoid arthritis. J Reumatol 1987;14:446-51.
16. Borodic GE, Joseph M, Fay L, Cozzolino D, Ferrante R. Botulinum toxin A for the treatment of spasmodic torticollis: dysphagia and regional toxin spread. Head Neck 1990;12:392-8.
17. 125I-labelled botulinum A neurotoxin: pharmocokinetics in cats, after intramuscular injection. Naunyn Schmiedebergs Arch Pharmacol 1976;292:161-5.
18. Garner CG, Strube A, Witt TN, Gasser T, Oetal WH. Time course of distant effects of local injections of botulinum toxin. Mov disord 1993;8:33-7.